GRB2 and acute kidney injury: To delineate the pathogenic mechanisms by which increased Grb2 promotes cardiac dysfunction, a specific antagonist of Grb2 (TB03) was injected into mice 30 min before renal ischemia–reperfusion surgery to fully block the activation of Grb2 during or after AKI.